Companies /Healthcare

Avantor Inc

NYSE: AVTR Medical Instruments & Supplies
$15.59
▼ $0.02 (−0.13%) today
Markets closed · 3:00am ET

24/7 Wall St. View

AVTR at a Glance

Valuation
Market cap
$10.6B
P/E ratio
31.9
Profitability
Revenue (TTM)
$6.6B
Profit margin
5.1%
EPS (TTM)
$0.49
Price
52-week range
$7 – $17
24/7 target
$18.28
Street target
$17.35

Headquartered in Radnor, PA Fiscal year ends December NYSE: AVTR avantorsciences.com

About Avantor

Avantor, Inc. (NYSE: AVTR) is a global life science tools company providing mission-critical products and services to customers in the life sciences and advanced technology industries. The company operates through two segments: VWR Distribution & Services, which distributes laboratory supplies, chemicals, and equipment, and Bioscience & Medtech Products, which offers proprietary bioscience reagents, silicone-based materials, and other specialty products used in research, development, and production. Avantor's portfolio is used in virtually every stage of important research, development, and production activities at more than 300,000 customer locations across 180 countries. The company serves pharmaceutical, biotechnology, healthcare, semiconductor, and industrial customers, working alongside them at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Updated

Latest Activity

AVTRAvantor
Q3 2026
EPS
$0.22
est $0.21+5.6%
Revenue
$1.70B
est $1.64B+3.5%

Avantor's turnaround finally shows up in the numbers: both segments grew organically and management raised full-year organic revenue growth guidance to +0.75% to +1.25%, up from a range that started negative.

Quarterly EPS — reported vs estimate

AVTR Coverage

Frequently Asked Questions

What does Avantor do?

Avantor, Inc. (NYSE: AVTR) is a global life science tools company providing mission-critical products and services to customers in the life sciences and advanced technology industries.

What is the AVTR stock price target?

24/7 Wall St.'s 12-month price target for AVTR is $18.28, rated Buy. The Wall Street consensus target is $17.35. AVTR price prediction →